ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2314

Improved Anxiety, Depression, and Emotional Distress for Rheumatoid Arthritis Patients Following the Completion of an Online Mental Health Intervention

Caitlin Blaney1, Carol Hitchon 1, Ruth Ann Marrie 2, Corey Mackenzie 1, Pamela Holens 1 and Renée El-Gabalawy 2, 1University of Manitoba, Winnipeg, Canada, 2University of Manitoba, Winnipeg, MB, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: mental health and online resources, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Background: Anxiety and depression are common in people with rheumatoid arthritis (RA). These comorbidities are associated with worse disease outcomes including pain and functional disability. Thus, treating mental health comorbidity is an important component of RA care. Given access to clinical mental health resources are limited, we evaluated the potential benefit of an online mental health intervention (i.e., self-directed cognitive behavioral therapy/CBT) for reducing mental health symptoms and improving quality of life in individuals with RA.

Methods: Methods: RA participants with self-reported clinically significant anxiety (n=38, 89% female) were enrolled. Participants completed The Worry and Sadness program, a validated, 6-module course including psychoeducation and strategies for self-management developed by an Australian research group. The program was completed, at home, over 12 weeks. Mental health outcomes were assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) scales for anxiety and depression, the Kessler Psychological Distress Scale (K-10) for emotional distress, and the PROMIS scale for physical-health related quality of life. Arthritis outcomes were assessed with the modified health assessment questionnaire (mHAQ) for physical function, PROMIS scales for pain and fatigue, and a patient-reported verbal assessment for disease activity. Measures obtained before and after completing the program were compared using paired Student t-tests. Participants also rated the usefulness of the program.

Results: Results: Participants who have completed the program (n=23) were predominantly female (mean age=59.4 years, standard deviation/SD=11.36). Immediately after completing the program, anxiety (mean difference pre-program versus post-program=4.13, SD=3.53, t(22)=5.61, p< 0.001), depression (mean difference pre-program versus post-program=2.57, SD=2.71, t(22)=4.54, p< 0.001), and emotional distress (mean difference pre-program versus post-program=7.81, SD=7.15, t(20)=5.01, p< 0.001) scores were all significantly reduced (Figure). Quality of life was unchanged, as were arthritis outcomes. Components of the program endorsed as useful to participants included identifying problematic thoughts, whereas reducing behavioural avoidance was considered less helpful.

Conclusion: Conclusions: Mental health symptoms experienced by RA patients improved after completing the Worry and Sadness online program, however, the program might benefit from adaptation to meet the needs of persons living with RA. Online tools are one feasible strategy to address the mental health needs of persons with RA, particularly in regions with limited clinical mental services.

Figure: Pre-post comparisons of anxiety, depression, and emotional distress using the PROMIS Anxiety, PROMIS Depression, and Kessler Psychological Distress Scale -K-10-.


Disclosure: C. Blaney, None; C. Hitchon, Pfizer, 2, UCB, 2, UCB Canada, 2; R. Marrie, None; C. Mackenzie, None; P. Holens, None; R. El-Gabalawy, None.

To cite this abstract in AMA style:

Blaney C, Hitchon C, Marrie R, Mackenzie C, Holens P, El-Gabalawy R. Improved Anxiety, Depression, and Emotional Distress for Rheumatoid Arthritis Patients Following the Completion of an Online Mental Health Intervention [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/improved-anxiety-depression-and-emotional-distress-for-rheumatoid-arthritis-patients-following-the-completion-of-an-online-mental-health-intervention/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improved-anxiety-depression-and-emotional-distress-for-rheumatoid-arthritis-patients-following-the-completion-of-an-online-mental-health-intervention/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology